ADAMDEC1

Across TCGA pan-cancer cohorts, ADAMDEC1 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ADAMDEC1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where ADAMDEC1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ADAMDEC1 is over-expressed in tumor, although a few such as COAD and CCRCC show the opposite, repressed pattern.

LSCC, COAD, and CCRCC are the cancer types where ADAMDEC1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ADAMDEC1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	III,IV	+1.061	<.001	8	view →
COAD	Female	II,III,IV	−0.558	<.001	7	view →
CCRCC	Male	All	−0.540	<.001	6	view →
LUAD	All	All	+0.312	.001	5	view →
HNSC	All	III,IV	+0.426	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ADAMDEC1–LSCC

Open the LSCC breakdown →